Therapeutic agent for glaucoma

Details Therapeutic agent for glaucoma Therapeutic agent for glaucoma

A - Human Necessities

61

K

A61K 31/54 (2006.01)

Patent

CA 2056670

A therapeutic agent for glaucoma comprises (+)-(R)-3,4-Dihydro-2-[5-methoxy-2-[3-[N-methyl-N-[2-[(3,4-methylenedioxy) phenoxy]ethyl]amino]propoxy]phenyl]-4-methyl-3-oxo-2H-1,4-benzothiazine or its salt as active ingredient and pharmaceutically acceptable excipients. The therapeutic agent lowers the intraocular pressure upon topical or systemic administration.

Un agent thérapeutique actif contre le glaucome comprend de la (+)-(R)-3,4-dihydro-2-[5-méthoxy-2-[3-[N-méthyl-N-[2-[(3,4-méthylènedioxy) phénoxy]éthyl]amino]propoxy]phényl]-4-méthyl-3-oxo-2H-1,4-benzothiazine, ou son sel, comme principe actif ainsi que des excipients pharmaceutiquement acceptables. L'agent thérapeutique, que l'on peut administrer par voie topique ou par voie générale, a pour effet d'abaisser la pression intraoculaire.

Affiliated with

Also associated with

Rating

Therapeutic agent for glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for glaucoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2047741